Literature DB >> 30302651

Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition.

Lars J Lindberg1, Wia Wegen-Haitsma2, Steen Ladelund2, Lars Smith-Hansen2, Christina Therkildsen2, Inge Bernstein3, Mef Nilbert2,4,5.   

Abstract

Development of multiple colorectal cancers (CRCs), synchronously or metachronously, is associated with hereditary predisposition for cancer and accurate risk estimates of multiple tumour development are relevant to recommend rational surveillance programs. A cross-sectional study design was used to estimate the risks of synchronous CRC (SCRC) and metachronous CRC (MCRC) based on data from the National Danish Hereditary Nonpolyposis Register. In total, 7100 individuals from families within the subgroups Lynch syndrome, familial CRC (FCC) and moderate risk were used with estimates relative to a non-hereditary population control cohort. SCRC was diagnosed in 7.4% of the Lynch syndrome cases, in 4.2% of FCC cases and 2.5% of the moderate risk cases, which translated to relative risks of 1.9-5.6. The risk of MCRC was distinctively linked to Lynch syndrome with a life-time risk up to 70% and an incidence rate ratio of 5.0. The risk of SCRC was significantly increased in all subgroups of FCC and hereditary CRC, whereas the risk of MCRC was specifically linked to Lynch syndrome. These observations suggest that individuals with FCC or hereditary CRC should be carefully screened for second primary CRC at the time of diagnosis, whereas intensified surveillance for second primary CRC is motivated in Lynch syndrome with lower-intensity programs in families with yet unidentified genetic causes.

Entities:  

Keywords:  Colonoscopy; Cross-sectional study; HNPCC; Lynch syndrome; Metachronous neoplasms; Multiple primary neoplasms; Synchronous neoplasms

Mesh:

Year:  2019        PMID: 30302651     DOI: 10.1007/s10689-018-0109-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  36 in total

Review 1.  Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.

Authors:  Priyanka Kanth; Jade Grimmett; Marjan Champine; Randall Burt; N Jewel Samadder
Journal:  Am J Gastroenterol       Date:  2017-08-08       Impact factor: 10.864

2.  One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

Authors:  Hans F A Vasen; Mohamed Abdirahman; Richard Brohet; Alexandra M J Langers; Jan H Kleibeuker; Mariette van Kouwen; Jan Jacob Koornstra; Henk Boot; Annemieke Cats; Evelien Dekker; Silvia Sanduleanu; Jan-Werner Poley; James C H Hardwick; Wouter H de Vos Tot Nederveen Cappel; Andrea E van der Meulen-de Jong; T Gie Tan; Maarten A J M Jacobs; Faig Lall A Mohamed; Sijbrand Y de Boer; Paul C van de Meeberg; Marie-Louise Verhulst; Jan M Salemans; Nico van Bentem; B Dik Westerveld; Juda Vecht; Fokko M Nagengast
Journal:  Gastroenterology       Date:  2010-03-02       Impact factor: 22.682

3.  Surgery for colonic cancer in HNPCC: total vs segmental colectomy.

Authors:  D A Stupart; P A Goldberg; R J Baigrie; U Algar; R Ramesar
Journal:  Colorectal Dis       Date:  2011-12       Impact factor: 3.788

4.  Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.

Authors:  Laura Renkonen-Sinisalo; Toni T Seppälä; Heikki J Järvinen; Jukka-Pekka Mecklin
Journal:  Dis Colon Rectum       Date:  2017-08       Impact factor: 4.585

5.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

Authors:  Noralane M Lindor; Kari Rabe; Gloria M Petersen; Robert Haile; Graham Casey; John Baron; Steve Gallinger; Bharati Bapat; Melyssa Aronson; John Hopper; Jeremy Jass; Loic LeMarchand; John Grove; John Potter; Polly Newcomb; Jonathan P Terdiman; Peggy Conrad; Gabriella Moslein; Richard Goldberg; Argyrios Ziogas; Hoda Anton-Culver; Mariza de Andrade; Kim Siegmund; Stephen N Thibodeau; Lisa A Boardman; Daniela Seminara
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

6.  Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma.

Authors:  J C Box; M A Rodriguez-Bigas; T K Weber; N J Petrelli
Journal:  Dis Colon Rectum       Date:  1999-06       Impact factor: 4.585

7.  Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study.

Authors:  Sanna A Mulder; Ries Kranse; Ronald A Damhuis; Johannes H W de Wilt; Rob J Th Ouwendijk; Ernst J Kuipers; Monique E van Leerdam
Journal:  Cancer Epidemiol       Date:  2011-04-05       Impact factor: 2.984

8.  Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma.

Authors:  R Fante; L Roncucci; M G Tamassia; L Losi; P Benatti; M Pedroni; A Percesepe; S De Pietri; M Ponz de Leon
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

9.  Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers.

Authors:  Aung Ko Win; Susan Parry; Bryan Parry; Matthew F Kalady; Finlay A Macrae; Dennis J Ahnen; Graeme P Young; Lara Lipton; Ingrid Winship; Alex Boussioutas; Joanne P Young; Daniel D Buchanan; Julie Arnold; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins
Journal:  Ann Surg Oncol       Date:  2013-01-29       Impact factor: 5.344

10.  Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.

Authors:  Pål Møller; Toni Seppälä; Inge Bernstein; Elke Holinski-Feder; Paola Sala; D Gareth Evans; Annika Lindblom; Finlay Macrae; Ignacio Blanco; Rolf Sijmons; Jacqueline Jeffries; Hans Vasen; John Burn; Sigve Nakken; Eivind Hovig; Einar Andreas Rødland; Kukatharmini Tharmaratnam; Wouter H de Vos Tot Nederveen Cappel; James Hill; Juul Wijnen; Mark Jenkins; Kate Green; Fiona Lalloo; Lone Sunde; Miriam Mints; Lucio Bertario; Marta Pineda; Matilde Navarro; Monika Morak; Laura Renkonen-Sinisalo; Ian M Frayling; John-Paul Plazzer; Kirsi Pylvanainen; Maurizio Genuardi; Jukka-Pekka Mecklin; Gabriela Möslein; Julian R Sampson; Gabriel Capella
Journal:  Gut       Date:  2016-06-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.